Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (28975)	6/26/1999 12:37:00 AM
From: bob zagorin	Respond to of 32384

new issue of CTSL focusing on biotech mergers in wake of SUGN. LGND is on their short list although their financial analysis is too complex for me to summarize. meanwhile here's another NR that includes LGND. 1999 International Biotech and Infotech Summit to be Broadcast by Investor Broadcast Network Over the Internet PHILADELPHIA--(BUSINESS WIRE)--June 25, 1999--Chiron Corporation (NASDAQ: CHIR) Founder and Director Edward Penhoet, Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) CEO David Robinson, Incyte Pharmaceuticals, Inc. (NASDAQ: INCY) President and CSO Randal Scott, Genset (NASDAQ: GENXY) Chairman and CEO Pascal Brandys, Geron Corporation (NASDAQ: GERN) CEO Ron Eastman, Gilead Sciences, Inc (NASDAQ: GILD) CEO John Martin, and Pharmacopeia, Inc. (NASDAQ: PCOP) President and Chief Operation Officer Lewis Suster are among the day one panelists at the 1999 International Biotech and Infotech Summit, which will be broadcast over the Internet, the Investor Broadcast Network (f/k/a Vcall) announced. Day one of this two day event will begin on Monday, June 28, 1999, at 11:25 AM EDT (8:25 AM PDT). The panel topics for the first day of the Summit include: -- Structuring the Industry to Create Value and Attract Capital -- When Bottlenecks Yield Business Opportunities -- Next Generation Technologies: Changing The Face of Drug Development -- The Biotech Product Pipeline: Driving Value for Investors In addition to the panel discussions, there will also be a keynote address delivered by Dr. Jane E. Henney, Commissioner of Food and Drugs, Food and Drug Administration, Department of Health and Human Services. The Summit can be accessed through the Investor Broadcast Network's Vcall website, located at vcall.com. Listeners should go to the website at least fifteen minutes before the event to register, download, and install any necessary audio software. For more information and the schedule for the event, please visit either the Vcall website or the Summit's website located at biotechsummit.com. For those unable to attend the live broadcast, a replay will be available beginning approximately one hour after the event. There is no charge to access this event. About Investor Broadcast Network Investor Broadcast Network, founded as Vcall in 1997, is the leading broadcaster of investor events serving over 400 public companies. The Company provides compelling investor content direct from companies and experts to more than 185,000 registered users through its Vcall, RadioWallStreet and Investor Conference broadcast services. Currently all events may be accessed through the Vcall service, located at vcall.com. For more information on Investor Broadcast Network visit www.investorbroadcast.com CONTACT: Investor Broadcast Network, Philadelphia Ron Matthews, 215/814-6550 TICKERS: NASDAQ:CHIR NASDAQ:LGND NASDAQ:INCY NASDAQ:GENXY NASDAQ:GERN NASDAQ:GILD NASDAQ:PCOP